These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


86 related items for PubMed ID: 6508226

  • 1. The effect of BCG-vaccine upon experimental visceral leishmaniasis in hamsters.
    Jarecki-Black JC, Glassman AB, Holbrook TW.
    Ann Clin Lab Sci; 1984; 14(6):464-6. PubMed ID: 6508226
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P, Gupta SK, Sinha S, Sundar S, Dube A, Naik S.
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbiéri CL, Uliana SR.
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [Abstract] [Full Text] [Related]

  • 4. [Experimental visceral leishmaniasis in golden hamsters].
    Shukina EE, Gorbunova LA.
    Parazitologiia; 1987 Feb; 21(5):637-42. PubMed ID: 3431905
    [Abstract] [Full Text] [Related]

  • 5. The effect of BCG on experimental cutaneous leishmaniasis in mice.
    Weintraub J, Weinbaum FI.
    J Immunol; 1977 Jun; 118(6):2288-90. PubMed ID: 864260
    [Abstract] [Full Text] [Related]

  • 6. Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice.
    Smrkovski LL, Larson CL.
    Infect Immun; 1977 Apr; 16(1):249-57. PubMed ID: 873609
    [Abstract] [Full Text] [Related]

  • 7. Effect of hydroxyethyl starch (HES) in reducing parasite load in experimental visceral leishmaniasis.
    Jarecki-Black JC, Atkins L, Pratt KM, Pepkowitz SH, Glassman AB.
    Ann Clin Lab Sci; 1986 Apr; 16(6):450-4. PubMed ID: 2432827
    [Abstract] [Full Text] [Related]

  • 8. Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum.
    Binhazim AA, Shin SS, Chapman WL, Olobo J.
    Lab Anim Sci; 1993 Feb; 43(1):37-47. PubMed ID: 8459677
    [Abstract] [Full Text] [Related]

  • 9. Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters.
    Murthy PK, Dixit S, Gaur RL, Kumar R, Sahoo MK, Shakya N, Joseph SK, Palne S, Gupta S.
    Acta Trop; 2008 May; 106(2):81-9. PubMed ID: 18329620
    [Abstract] [Full Text] [Related]

  • 10. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 11. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R, Gupta SK, Tripathi P, Hajela K, Sundar S, Naik S, Dube A.
    Vaccine; 2006 Apr 05; 24(15):2900-9. PubMed ID: 16448729
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis.
    Srivastava JK, Misra A, Sharma P, Srivastava B, Naik S, Dube A.
    Parasitology; 2003 Aug 05; 127(Pt 2):107-14. PubMed ID: 12954011
    [Abstract] [Full Text] [Related]

  • 13. Immunization of hamsters with TLCK-killed parasites induces protection against Leishmania infection.
    O'Daly JA, Cabrera Z.
    Acta Trop; 1986 Sep 05; 43(3):225-36. PubMed ID: 2877549
    [Abstract] [Full Text] [Related]

  • 14. Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection.
    Mittal N, Gupta N, Goyal N, Singh AK, Guru PY, Pandey VC, Rastogi AK.
    Indian J Exp Biol; 1997 Apr 05; 35(4):393-6. PubMed ID: 9315242
    [Abstract] [Full Text] [Related]

  • 15. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A.
    Vaccine; 2008 Oct 23; 26(45):5700-11. PubMed ID: 18762224
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of human beta-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters.
    Sharma P, Singh N, Garg R, Haq W, Dube A.
    Peptides; 2004 Nov 23; 25(11):1873-81. PubMed ID: 15501518
    [Abstract] [Full Text] [Related]

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 23; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sensitization of offspring of Leishmania donovani-infected hamsters to immunization and of offspring of immunized hamsters to challenge.
    Herman R, Nolan TJ, Fahey JR.
    Am J Trop Med Hyg; 1982 Jul 23; 31(4):730-9. PubMed ID: 7201750
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.